Medical Care
Global Sepsis Diagnostic Market Research Report 2025
- Sep 09, 25
- ID: 494306
- Pages: 83
- Figures: 89
- Views: 19
This report aims to provide a comprehensive presentation of the global market for Sepsis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Diagnostic.
The Sepsis Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sepsis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bruker (US)
CytoSorbents (US)
EKF (US)
T2 Biosystems (US)
Luminex (US)
Thermo Fisher Scientific (US)
bioMerieux (France)
Danaher (US)
Becton, Dickinson and Company (US)
Roche (Switzerland)
Abbott (US)
Segment by Type
Laboratory Tests
Point-of-care Tests
Segment by Application
Hospitals
Pathology & Reference Laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Sepsis Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sepsis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bruker (US)
CytoSorbents (US)
EKF (US)
T2 Biosystems (US)
Luminex (US)
Thermo Fisher Scientific (US)
bioMerieux (France)
Danaher (US)
Becton, Dickinson and Company (US)
Roche (Switzerland)
Abbott (US)
Segment by Type
Laboratory Tests
Point-of-care Tests
Segment by Application
Hospitals
Pathology & Reference Laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Laboratory Tests
1.2.3 Point-of-care Tests
1.3 Market by Application
1.3.1 Global Sepsis Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2020-2031)
2.2 Global Sepsis Diagnostic Growth Trends by Region
2.2.1 Global Sepsis Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sepsis Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Sepsis Diagnostic Market Dynamics
2.3.1 Sepsis Diagnostic Industry Trends
2.3.2 Sepsis Diagnostic Market Drivers
2.3.3 Sepsis Diagnostic Market Challenges
2.3.4 Sepsis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostic Players by Revenue
3.1.1 Global Top Sepsis Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sepsis Diagnostic Revenue
3.4 Global Sepsis Diagnostic Market Concentration Ratio
3.4.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2024
3.5 Global Key Players of Sepsis Diagnostic Head office and Area Served
3.6 Global Key Players of Sepsis Diagnostic, Product and Application
3.7 Global Key Players of Sepsis Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostic Breakdown Data by Type
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2026-2031)
5 Sepsis Diagnostic Breakdown Data by Application
5.1 Global Sepsis Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sepsis Diagnostic Market Size (2020-2031)
6.2 North America Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sepsis Diagnostic Market Size by Country (2020-2025)
6.4 North America Sepsis Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2020-2031)
7.2 Europe Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sepsis Diagnostic Market Size by Country (2020-2025)
7.4 Europe Sepsis Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Sepsis Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sepsis Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Sepsis Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostic Market Size (2020-2031)
9.2 Latin America Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sepsis Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Sepsis Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sepsis Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Sepsis Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker (US)
11.1.1 Bruker (US) Company Details
11.1.2 Bruker (US) Business Overview
11.1.3 Bruker (US) Sepsis Diagnostic Introduction
11.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.1.5 Bruker (US) Recent Development
11.2 CytoSorbents (US)
11.2.1 CytoSorbents (US) Company Details
11.2.2 CytoSorbents (US) Business Overview
11.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
11.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.2.5 CytoSorbents (US) Recent Development
11.3 EKF (US)
11.3.1 EKF (US) Company Details
11.3.2 EKF (US) Business Overview
11.3.3 EKF (US) Sepsis Diagnostic Introduction
11.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.3.5 EKF (US) Recent Development
11.4 T2 Biosystems (US)
11.4.1 T2 Biosystems (US) Company Details
11.4.2 T2 Biosystems (US) Business Overview
11.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
11.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.4.5 T2 Biosystems (US) Recent Development
11.5 Luminex (US)
11.5.1 Luminex (US) Company Details
11.5.2 Luminex (US) Business Overview
11.5.3 Luminex (US) Sepsis Diagnostic Introduction
11.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.5.5 Luminex (US) Recent Development
11.6 Thermo Fisher Scientific (US)
11.6.1 Thermo Fisher Scientific (US) Company Details
11.6.2 Thermo Fisher Scientific (US) Business Overview
11.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
11.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.6.5 Thermo Fisher Scientific (US) Recent Development
11.7 bioMerieux (France)
11.7.1 bioMerieux (France) Company Details
11.7.2 bioMerieux (France) Business Overview
11.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
11.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2020-2025)
11.7.5 bioMerieux (France) Recent Development
11.8 Danaher (US)
11.8.1 Danaher (US) Company Details
11.8.2 Danaher (US) Business Overview
11.8.3 Danaher (US) Sepsis Diagnostic Introduction
11.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.8.5 Danaher (US) Recent Development
11.9 Becton, Dickinson and Company (US)
11.9.1 Becton, Dickinson and Company (US) Company Details
11.9.2 Becton, Dickinson and Company (US) Business Overview
11.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
11.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.9.5 Becton, Dickinson and Company (US) Recent Development
11.10 Roche (Switzerland)
11.10.1 Roche (Switzerland) Company Details
11.10.2 Roche (Switzerland) Business Overview
11.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
11.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2020-2025)
11.10.5 Roche (Switzerland) Recent Development
11.11 Abbott (US)
11.11.1 Abbott (US) Company Details
11.11.2 Abbott (US) Business Overview
11.11.3 Abbott (US) Sepsis Diagnostic Introduction
11.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.11.5 Abbott (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Laboratory Tests
1.2.3 Point-of-care Tests
1.3 Market by Application
1.3.1 Global Sepsis Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2020-2031)
2.2 Global Sepsis Diagnostic Growth Trends by Region
2.2.1 Global Sepsis Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sepsis Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Sepsis Diagnostic Market Dynamics
2.3.1 Sepsis Diagnostic Industry Trends
2.3.2 Sepsis Diagnostic Market Drivers
2.3.3 Sepsis Diagnostic Market Challenges
2.3.4 Sepsis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostic Players by Revenue
3.1.1 Global Top Sepsis Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sepsis Diagnostic Revenue
3.4 Global Sepsis Diagnostic Market Concentration Ratio
3.4.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2024
3.5 Global Key Players of Sepsis Diagnostic Head office and Area Served
3.6 Global Key Players of Sepsis Diagnostic, Product and Application
3.7 Global Key Players of Sepsis Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostic Breakdown Data by Type
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2026-2031)
5 Sepsis Diagnostic Breakdown Data by Application
5.1 Global Sepsis Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sepsis Diagnostic Market Size (2020-2031)
6.2 North America Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sepsis Diagnostic Market Size by Country (2020-2025)
6.4 North America Sepsis Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2020-2031)
7.2 Europe Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sepsis Diagnostic Market Size by Country (2020-2025)
7.4 Europe Sepsis Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Sepsis Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sepsis Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Sepsis Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostic Market Size (2020-2031)
9.2 Latin America Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sepsis Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Sepsis Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Sepsis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sepsis Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Sepsis Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker (US)
11.1.1 Bruker (US) Company Details
11.1.2 Bruker (US) Business Overview
11.1.3 Bruker (US) Sepsis Diagnostic Introduction
11.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.1.5 Bruker (US) Recent Development
11.2 CytoSorbents (US)
11.2.1 CytoSorbents (US) Company Details
11.2.2 CytoSorbents (US) Business Overview
11.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
11.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.2.5 CytoSorbents (US) Recent Development
11.3 EKF (US)
11.3.1 EKF (US) Company Details
11.3.2 EKF (US) Business Overview
11.3.3 EKF (US) Sepsis Diagnostic Introduction
11.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.3.5 EKF (US) Recent Development
11.4 T2 Biosystems (US)
11.4.1 T2 Biosystems (US) Company Details
11.4.2 T2 Biosystems (US) Business Overview
11.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
11.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.4.5 T2 Biosystems (US) Recent Development
11.5 Luminex (US)
11.5.1 Luminex (US) Company Details
11.5.2 Luminex (US) Business Overview
11.5.3 Luminex (US) Sepsis Diagnostic Introduction
11.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.5.5 Luminex (US) Recent Development
11.6 Thermo Fisher Scientific (US)
11.6.1 Thermo Fisher Scientific (US) Company Details
11.6.2 Thermo Fisher Scientific (US) Business Overview
11.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
11.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.6.5 Thermo Fisher Scientific (US) Recent Development
11.7 bioMerieux (France)
11.7.1 bioMerieux (France) Company Details
11.7.2 bioMerieux (France) Business Overview
11.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
11.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2020-2025)
11.7.5 bioMerieux (France) Recent Development
11.8 Danaher (US)
11.8.1 Danaher (US) Company Details
11.8.2 Danaher (US) Business Overview
11.8.3 Danaher (US) Sepsis Diagnostic Introduction
11.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.8.5 Danaher (US) Recent Development
11.9 Becton, Dickinson and Company (US)
11.9.1 Becton, Dickinson and Company (US) Company Details
11.9.2 Becton, Dickinson and Company (US) Business Overview
11.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
11.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.9.5 Becton, Dickinson and Company (US) Recent Development
11.10 Roche (Switzerland)
11.10.1 Roche (Switzerland) Company Details
11.10.2 Roche (Switzerland) Business Overview
11.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
11.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2020-2025)
11.10.5 Roche (Switzerland) Recent Development
11.11 Abbott (US)
11.11.1 Abbott (US) Company Details
11.11.2 Abbott (US) Business Overview
11.11.3 Abbott (US) Sepsis Diagnostic Introduction
11.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2020-2025)
11.11.5 Abbott (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Point-of-care Tests
Table 4. Global Sepsis Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sepsis Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sepsis Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sepsis Diagnostic Market Share by Region (2020-2025)
Table 8. Global Sepsis Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sepsis Diagnostic Market Share by Region (2026-2031)
Table 10. Sepsis Diagnostic Market Trends
Table 11. Sepsis Diagnostic Market Drivers
Table 12. Sepsis Diagnostic Market Challenges
Table 13. Sepsis Diagnostic Market Restraints
Table 14. Global Sepsis Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sepsis Diagnostic Market Share by Players (2020-2025)
Table 16. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2024)
Table 17. Ranking of Global Top Sepsis Diagnostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sepsis Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of Sepsis Diagnostic, Product and Application
Table 21. Global Key Players of Sepsis Diagnostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sepsis Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sepsis Diagnostic Revenue Market Share by Type (2020-2025)
Table 25. Global Sepsis Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sepsis Diagnostic Revenue Market Share by Type (2026-2031)
Table 27. Global Sepsis Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sepsis Diagnostic Revenue Market Share by Application (2020-2025)
Table 29. Global Sepsis Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sepsis Diagnostic Revenue Market Share by Application (2026-2031)
Table 31. North America Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sepsis Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sepsis Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sepsis Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bruker (US) Company Details
Table 47. Bruker (US) Business Overview
Table 48. Bruker (US) Sepsis Diagnostic Product
Table 49. Bruker (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 50. Bruker (US) Recent Development
Table 51. CytoSorbents (US) Company Details
Table 52. CytoSorbents (US) Business Overview
Table 53. CytoSorbents (US) Sepsis Diagnostic Product
Table 54. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 55. CytoSorbents (US) Recent Development
Table 56. EKF (US) Company Details
Table 57. EKF (US) Business Overview
Table 58. EKF (US) Sepsis Diagnostic Product
Table 59. EKF (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 60. EKF (US) Recent Development
Table 61. T2 Biosystems (US) Company Details
Table 62. T2 Biosystems (US) Business Overview
Table 63. T2 Biosystems (US) Sepsis Diagnostic Product
Table 64. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 65. T2 Biosystems (US) Recent Development
Table 66. Luminex (US) Company Details
Table 67. Luminex (US) Business Overview
Table 68. Luminex (US) Sepsis Diagnostic Product
Table 69. Luminex (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 70. Luminex (US) Recent Development
Table 71. Thermo Fisher Scientific (US) Company Details
Table 72. Thermo Fisher Scientific (US) Business Overview
Table 73. Thermo Fisher Scientific (US) Sepsis Diagnostic Product
Table 74. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific (US) Recent Development
Table 76. bioMerieux (France) Company Details
Table 77. bioMerieux (France) Business Overview
Table 78. bioMerieux (France) Sepsis Diagnostic Product
Table 79. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 80. bioMerieux (France) Recent Development
Table 81. Danaher (US) Company Details
Table 82. Danaher (US) Business Overview
Table 83. Danaher (US) Sepsis Diagnostic Product
Table 84. Danaher (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 85. Danaher (US) Recent Development
Table 86. Becton, Dickinson and Company (US) Company Details
Table 87. Becton, Dickinson and Company (US) Business Overview
Table 88. Becton, Dickinson and Company (US) Sepsis Diagnostic Product
Table 89. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 90. Becton, Dickinson and Company (US) Recent Development
Table 91. Roche (Switzerland) Company Details
Table 92. Roche (Switzerland) Business Overview
Table 93. Roche (Switzerland) Sepsis Diagnostic Product
Table 94. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 95. Roche (Switzerland) Recent Development
Table 96. Abbott (US) Company Details
Table 97. Abbott (US) Business Overview
Table 98. Abbott (US) Sepsis Diagnostic Product
Table 99. Abbott (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 100. Abbott (US) Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Sepsis Diagnostic Picture
Figure 2. Global Sepsis Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sepsis Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Laboratory Tests Features
Figure 5. Point-of-care Tests Features
Figure 6. Global Sepsis Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sepsis Diagnostic Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Pathology & Reference Laboratories Case Studies
Figure 10. Sepsis Diagnostic Report Years Considered
Figure 11. Global Sepsis Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Sepsis Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sepsis Diagnostic Market Share by Region: 2024 VS 2031
Figure 14. Global Sepsis Diagnostic Market Share by Players in 2024
Figure 15. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2024
Figure 17. North America Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 19. United States Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 23. Germany Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sepsis Diagnostic Market Share by Region (2020-2031)
Figure 31. China Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 39. Mexico Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 43. Turkey Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Bruker (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 47. CytoSorbents (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 48. EKF (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 49. T2 Biosystems (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 50. Luminex (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 51. Thermo Fisher Scientific (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 52. bioMerieux (France) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 53. Danaher (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 54. Becton, Dickinson and Company (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 55. Roche (Switzerland) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 56. Abbott (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Point-of-care Tests
Table 4. Global Sepsis Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Sepsis Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sepsis Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Sepsis Diagnostic Market Share by Region (2020-2025)
Table 8. Global Sepsis Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Sepsis Diagnostic Market Share by Region (2026-2031)
Table 10. Sepsis Diagnostic Market Trends
Table 11. Sepsis Diagnostic Market Drivers
Table 12. Sepsis Diagnostic Market Challenges
Table 13. Sepsis Diagnostic Market Restraints
Table 14. Global Sepsis Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Sepsis Diagnostic Market Share by Players (2020-2025)
Table 16. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2024)
Table 17. Ranking of Global Top Sepsis Diagnostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Sepsis Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of Sepsis Diagnostic, Product and Application
Table 21. Global Key Players of Sepsis Diagnostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sepsis Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Sepsis Diagnostic Revenue Market Share by Type (2020-2025)
Table 25. Global Sepsis Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Sepsis Diagnostic Revenue Market Share by Type (2026-2031)
Table 27. Global Sepsis Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Sepsis Diagnostic Revenue Market Share by Application (2020-2025)
Table 29. Global Sepsis Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Sepsis Diagnostic Revenue Market Share by Application (2026-2031)
Table 31. North America Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Sepsis Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Sepsis Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Sepsis Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Sepsis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Sepsis Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Sepsis Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bruker (US) Company Details
Table 47. Bruker (US) Business Overview
Table 48. Bruker (US) Sepsis Diagnostic Product
Table 49. Bruker (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 50. Bruker (US) Recent Development
Table 51. CytoSorbents (US) Company Details
Table 52. CytoSorbents (US) Business Overview
Table 53. CytoSorbents (US) Sepsis Diagnostic Product
Table 54. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 55. CytoSorbents (US) Recent Development
Table 56. EKF (US) Company Details
Table 57. EKF (US) Business Overview
Table 58. EKF (US) Sepsis Diagnostic Product
Table 59. EKF (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 60. EKF (US) Recent Development
Table 61. T2 Biosystems (US) Company Details
Table 62. T2 Biosystems (US) Business Overview
Table 63. T2 Biosystems (US) Sepsis Diagnostic Product
Table 64. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 65. T2 Biosystems (US) Recent Development
Table 66. Luminex (US) Company Details
Table 67. Luminex (US) Business Overview
Table 68. Luminex (US) Sepsis Diagnostic Product
Table 69. Luminex (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 70. Luminex (US) Recent Development
Table 71. Thermo Fisher Scientific (US) Company Details
Table 72. Thermo Fisher Scientific (US) Business Overview
Table 73. Thermo Fisher Scientific (US) Sepsis Diagnostic Product
Table 74. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific (US) Recent Development
Table 76. bioMerieux (France) Company Details
Table 77. bioMerieux (France) Business Overview
Table 78. bioMerieux (France) Sepsis Diagnostic Product
Table 79. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 80. bioMerieux (France) Recent Development
Table 81. Danaher (US) Company Details
Table 82. Danaher (US) Business Overview
Table 83. Danaher (US) Sepsis Diagnostic Product
Table 84. Danaher (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 85. Danaher (US) Recent Development
Table 86. Becton, Dickinson and Company (US) Company Details
Table 87. Becton, Dickinson and Company (US) Business Overview
Table 88. Becton, Dickinson and Company (US) Sepsis Diagnostic Product
Table 89. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 90. Becton, Dickinson and Company (US) Recent Development
Table 91. Roche (Switzerland) Company Details
Table 92. Roche (Switzerland) Business Overview
Table 93. Roche (Switzerland) Sepsis Diagnostic Product
Table 94. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 95. Roche (Switzerland) Recent Development
Table 96. Abbott (US) Company Details
Table 97. Abbott (US) Business Overview
Table 98. Abbott (US) Sepsis Diagnostic Product
Table 99. Abbott (US) Revenue in Sepsis Diagnostic Business (2020-2025) & (US$ Million)
Table 100. Abbott (US) Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Sepsis Diagnostic Picture
Figure 2. Global Sepsis Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sepsis Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Laboratory Tests Features
Figure 5. Point-of-care Tests Features
Figure 6. Global Sepsis Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Sepsis Diagnostic Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Pathology & Reference Laboratories Case Studies
Figure 10. Sepsis Diagnostic Report Years Considered
Figure 11. Global Sepsis Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Sepsis Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sepsis Diagnostic Market Share by Region: 2024 VS 2031
Figure 14. Global Sepsis Diagnostic Market Share by Players in 2024
Figure 15. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2024
Figure 17. North America Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 19. United States Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 23. Germany Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Sepsis Diagnostic Market Share by Region (2020-2031)
Figure 31. China Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 39. Mexico Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Sepsis Diagnostic Market Share by Country (2020-2031)
Figure 43. Turkey Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Sepsis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Bruker (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 47. CytoSorbents (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 48. EKF (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 49. T2 Biosystems (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 50. Luminex (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 51. Thermo Fisher Scientific (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 52. bioMerieux (France) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 53. Danaher (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 54. Becton, Dickinson and Company (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 55. Roche (Switzerland) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 56. Abbott (US) Revenue Growth Rate in Sepsis Diagnostic Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232